 | • レポートコード：MRC308GR11367 • 出版社/出版日：GlobalInfoResearch / 2023年8月12日 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の甲状腺機能亢進症用抗甲状腺薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の甲状腺機能亢進症用抗甲状腺薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 甲状腺機能亢進症用抗甲状腺薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
甲状腺機能亢進症用抗甲状腺薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・メチマゾール、プロピルチオウラシル、その他
用途別セグメント
・病院、クリニック、その他
主要な市場プレーヤー
・Merck、Herbrand PharmaChemicals、Future Health Pharma、Shanghai Zhaohui Pharmaceutical、Beijing Yanjing Pharmaceutical、Jinghua Pharmaceutical Group、Guangzhou Kanghe Pharmaceutical、Zigong Honghe Pharmaceutical、Guangdong Huanan Pharmaceutical、Zibo Wankang Pharmaceutical Chemical、Qilu Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、甲状腺機能亢進症用抗甲状腺薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な甲状腺機能亢進症用抗甲状腺薬メーカーの企業概要、2019年～2022年までの甲状腺機能亢進症用抗甲状腺薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な甲状腺機能亢進症用抗甲状腺薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別甲状腺機能亢進症用抗甲状腺薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの甲状腺機能亢進症用抗甲状腺薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での甲状腺機能亢進症用抗甲状腺薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および甲状腺機能亢進症用抗甲状腺薬の産業チェーンを掲載しています。
・第14、15章では、甲状腺機能亢進症用抗甲状腺薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 甲状腺機能亢進症用抗甲状腺薬の概要
– 種類別分析（2018年vs2022年vs2029年）：メチマゾール、プロピルチオウラシル、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、クリニック、その他
– 世界の甲状腺機能亢進症用抗甲状腺薬市場規模・予測
– 世界の甲状腺機能亢進症用抗甲状腺薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Herbrand PharmaChemicals、Future Health Pharma、Shanghai Zhaohui Pharmaceutical、Beijing Yanjing Pharmaceutical、Jinghua Pharmaceutical Group、Guangzhou Kanghe Pharmaceutical、Zigong Honghe Pharmaceutical、Guangdong Huanan Pharmaceutical、Zibo Wankang Pharmaceutical Chemical、Qilu Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：メチマゾール、プロピルチオウラシル、その他
・用途別分析2018年-2029年：病院、クリニック、その他
・甲状腺機能亢進症用抗甲状腺薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・甲状腺機能亢進症用抗甲状腺薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・甲状腺機能亢進症用抗甲状腺薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・甲状腺機能亢進症用抗甲状腺薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・甲状腺機能亢進症用抗甲状腺薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Antithyroid Medications for Hyperthyroidism
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Methimazole
1.3.3 Propylthiouracil
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Antithyroid Medications for Hyperthyroidism Market Size & Forecast
1.5.1 Global Antithyroid Medications for Hyperthyroidism Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Antithyroid Medications for Hyperthyroidism Sales Quantity (2018-2029)
1.5.3 Global Antithyroid Medications for Hyperthyroidism Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Antithyroid Medications for Hyperthyroidism Product and Services
2.1.4 Merck Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Herbrand PharmaChemicals
2.2.1 Herbrand PharmaChemicals Details
2.2.2 Herbrand PharmaChemicals Major Business
2.2.3 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product and Services
2.2.4 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbrand PharmaChemicals Recent Developments/Updates
2.3 Future Health Pharma
2.3.1 Future Health Pharma Details
2.3.2 Future Health Pharma Major Business
2.3.3 Future Health Pharma Antithyroid Medications for Hyperthyroidism Product and Services
2.3.4 Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Future Health Pharma Recent Developments/Updates
2.4 Shanghai Zhaohui Pharmaceutical
2.4.1 Shanghai Zhaohui Pharmaceutical Details
2.4.2 Shanghai Zhaohui Pharmaceutical Major Business
2.4.3 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
2.4.4 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
2.5 Beijing Yanjing Pharmaceutical
2.5.1 Beijing Yanjing Pharmaceutical Details
2.5.2 Beijing Yanjing Pharmaceutical Major Business
2.5.3 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
2.5.4 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
2.6 Jinghua Pharmaceutical Group
2.6.1 Jinghua Pharmaceutical Group Details
2.6.2 Jinghua Pharmaceutical Group Major Business
2.6.3 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product and Services
2.6.4 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jinghua Pharmaceutical Group Recent Developments/Updates
2.7 Guangzhou Kanghe Pharmaceutical
2.7.1 Guangzhou Kanghe Pharmaceutical Details
2.7.2 Guangzhou Kanghe Pharmaceutical Major Business
2.7.3 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
2.7.4 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
2.8 Zigong Honghe Pharmaceutical
2.8.1 Zigong Honghe Pharmaceutical Details
2.8.2 Zigong Honghe Pharmaceutical Major Business
2.8.3 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
2.8.4 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
2.9 Guangdong Huanan Pharmaceutical
2.9.1 Guangdong Huanan Pharmaceutical Details
2.9.2 Guangdong Huanan Pharmaceutical Major Business
2.9.3 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
2.9.4 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
2.10 Zibo Wankang Pharmaceutical Chemical
2.10.1 Zibo Wankang Pharmaceutical Chemical Details
2.10.2 Zibo Wankang Pharmaceutical Chemical Major Business
2.10.3 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product and Services
2.10.4 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
2.11 Qilu Pharmaceutical
2.11.1 Qilu Pharmaceutical Details
2.11.2 Qilu Pharmaceutical Major Business
2.11.3 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
2.11.4 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Qilu Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Antithyroid Medications for Hyperthyroidism by Manufacturer
3.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Manufacturer (2018-2023)
3.2 Global Antithyroid Medications for Hyperthyroidism Revenue by Manufacturer (2018-2023)
3.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Antithyroid Medications for Hyperthyroidism by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Antithyroid Medications for Hyperthyroidism Manufacturer Market Share in 2022
3.4.2 Top 6 Antithyroid Medications for Hyperthyroidism Manufacturer Market Share in 2022
3.5 Antithyroid Medications for Hyperthyroidism Market: Overall Company Footprint Analysis
3.5.1 Antithyroid Medications for Hyperthyroidism Market: Region Footprint
3.5.2 Antithyroid Medications for Hyperthyroidism Market: Company Product Type Footprint
3.5.3 Antithyroid Medications for Hyperthyroidism Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Antithyroid Medications for Hyperthyroidism Market Size by Region
4.1.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2018-2029)
4.1.2 Global Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2018-2029)
4.1.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Region (2018-2029)
4.2 North America Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029)
4.3 Europe Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029)
4.4 Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029)
4.5 South America Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029)
4.6 Middle East and Africa Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2029)
5.2 Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type (2018-2029)
5.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2029)
6.2 Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application (2018-2029)
6.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Application (2018-2029)
7 North America
7.1 North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2029)
7.2 North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2029)
7.3 North America Antithyroid Medications for Hyperthyroidism Market Size by Country
7.3.1 North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2029)
7.3.2 North America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2029)
8.2 Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2029)
8.3 Europe Antithyroid Medications for Hyperthyroidism Market Size by Country
8.3.1 Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2029)
8.3.2 Europe Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Antithyroid Medications for Hyperthyroidism Market Size by Region
9.3.1 Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2029)
10.2 South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2029)
10.3 South America Antithyroid Medications for Hyperthyroidism Market Size by Country
10.3.1 South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2029)
10.3.2 South America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Antithyroid Medications for Hyperthyroidism Market Size by Country
11.3.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Antithyroid Medications for Hyperthyroidism Market Drivers
12.2 Antithyroid Medications for Hyperthyroidism Market Restraints
12.3 Antithyroid Medications for Hyperthyroidism Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Antithyroid Medications for Hyperthyroidism and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antithyroid Medications for Hyperthyroidism
13.3 Antithyroid Medications for Hyperthyroidism Production Process
13.4 Antithyroid Medications for Hyperthyroidism Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antithyroid Medications for Hyperthyroidism Typical Distributors
14.3 Antithyroid Medications for Hyperthyroidism Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Antithyroid Medications for Hyperthyroidism Product and Services
Table 6. Merck Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Herbrand PharmaChemicals Basic Information, Manufacturing Base and Competitors
Table 9. Herbrand PharmaChemicals Major Business
Table 10. Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product and Services
Table 11. Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbrand PharmaChemicals Recent Developments/Updates
Table 13. Future Health Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Future Health Pharma Major Business
Table 15. Future Health Pharma Antithyroid Medications for Hyperthyroidism Product and Services
Table 16. Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Future Health Pharma Recent Developments/Updates
Table 18. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Shanghai Zhaohui Pharmaceutical Major Business
Table 20. Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
Table 21. Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 23. Beijing Yanjing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Beijing Yanjing Pharmaceutical Major Business
Table 25. Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
Table 26. Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing Yanjing Pharmaceutical Recent Developments/Updates
Table 28. Jinghua Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 29. Jinghua Pharmaceutical Group Major Business
Table 30. Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product and Services
Table 31. Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Jinghua Pharmaceutical Group Recent Developments/Updates
Table 33. Guangzhou Kanghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Guangzhou Kanghe Pharmaceutical Major Business
Table 35. Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
Table 36. Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
Table 38. Zigong Honghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zigong Honghe Pharmaceutical Major Business
Table 40. Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
Table 41. Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Zigong Honghe Pharmaceutical Recent Developments/Updates
Table 43. Guangdong Huanan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Guangdong Huanan Pharmaceutical Major Business
Table 45. Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
Table 46. Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangdong Huanan Pharmaceutical Recent Developments/Updates
Table 48. Zibo Wankang Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
Table 49. Zibo Wankang Pharmaceutical Chemical Major Business
Table 50. Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product and Services
Table 51. Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
Table 53. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Qilu Pharmaceutical Major Business
Table 55. Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
Table 56. Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Qilu Pharmaceutical Recent Developments/Updates
Table 58. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Antithyroid Medications for Hyperthyroidism Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Antithyroid Medications for Hyperthyroidism Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Antithyroid Medications for Hyperthyroidism, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Antithyroid Medications for Hyperthyroidism Production Site of Key Manufacturer
Table 63. Antithyroid Medications for Hyperthyroidism Market: Company Product Type Footprint
Table 64. Antithyroid Medications for Hyperthyroidism Market: Company Product Application Footprint
Table 65. Antithyroid Medications for Hyperthyroidism New Market Entrants and Barriers to Market Entry
Table 66. Antithyroid Medications for Hyperthyroidism Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Antithyroid Medications for Hyperthyroidism Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Antithyroid Medications for Hyperthyroidism Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Antithyroid Medications for Hyperthyroidism Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Antithyroid Medications for Hyperthyroidism Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Antithyroid Medications for Hyperthyroidism Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Antithyroid Medications for Hyperthyroidism Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Antithyroid Medications for Hyperthyroidism Raw Material
Table 126. Key Manufacturers of Antithyroid Medications for Hyperthyroidism Raw Materials
Table 127. Antithyroid Medications for Hyperthyroidism Typical Distributors
Table 128. Antithyroid Medications for Hyperthyroidism Typical Customers
List of Figures
Figure 1. Antithyroid Medications for Hyperthyroidism Picture
Figure 2. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Type in 2022
Figure 4. Methimazole Examples
Figure 5. Propylthiouracil Examples
Figure 6. Other Examples
Figure 7. Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Antithyroid Medications for Hyperthyroidism Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Antithyroid Medications for Hyperthyroidism Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Antithyroid Medications for Hyperthyroidism Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Antithyroid Medications for Hyperthyroidism Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Antithyroid Medications for Hyperthyroidism by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Antithyroid Medications for Hyperthyroidism Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Antithyroid Medications for Hyperthyroidism Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Antithyroid Medications for Hyperthyroidism Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Antithyroid Medications for Hyperthyroidism Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Region (2018-2029)
Figure 54. China Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Antithyroid Medications for Hyperthyroidism Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Antithyroid Medications for Hyperthyroidism Market Drivers
Figure 75. Antithyroid Medications for Hyperthyroidism Market Restraints
Figure 76. Antithyroid Medications for Hyperthyroidism Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Antithyroid Medications for Hyperthyroidism in 2022
Figure 79. Manufacturing Process Analysis of Antithyroid Medications for Hyperthyroidism
Figure 80. Antithyroid Medications for Hyperthyroidism Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source